Male metabolism, hormone profiles, and body composition patterns genuinely differ from female patterns, and those differences affect how semaglutide and tirzepatide work in the body
The actual milligram dose depends entirely on your reconstitution concentration
AOD 9604 is a fragment of human growth hormone studied for its effect on fat metabolism, with a real but modest evidence base and an important regulatory caveat: it is not an FDA-approved weight loss drug
Morando L, Cesa R, Rasetti R, Harvey R, Strata P
Semaglutide may be appropriate for individuals who: Prefer an established GLP-1 treatment Have responded well to GLP-1 medications previously Require appetite management support Tirzepatide may be considered for individuals who: Need more aggressive weight reduction Have struggled with previous weight loss attempts May benefit from dual hormone pathway activation Ultimately, the most effective treatment is the one that aligns with your health profile, medical history, and long-term goals
If an eating disorder is involved, the ability of a GLP-1 to mute feelings of hunger and thoughts of food and simplify weight loss is both counterproductive and dangerous